Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled rats

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Christensen, Kenneth V ^a,b   Leffers, Henrik ^b   Watson, William P ^a,c   Sánchez, Connie ^a,d   Kallunki, Pekka ^a   Egebjerg, Jan ^a  

^a H LUNDBECK A S   (Denmark)

^b University of Copenhagen   (Denmark)

^c Barclays House   (United Kingdom)

^d LUNDBECK RESEARCH USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BETA A ACTIVIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CELL ADHESION MOLECULE; CELL PROTEIN; CYCLOOXYGENASE 2; EARLY GROWTH RESPONSE FACTOR 2; EARLY GROWTH RESPONSE FACTOR 3; ETIRACETAM; G PROTEIN COUPLED RECEPTOR; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN 3; PROTEIN ANIA 3; PROTEIN ARC; PROTEIN C FOS; PROTEIN HOMER 1A; PROTEIN KINASE PIM 1; PROTEIN NARP; PROTEIN TIEG1; PROTOCADHERIN 8; RGS2 PROTEIN; SYNAPTOPODIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; PIRACETAM;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; KINDLING; MALE; NERVE CELL PLASTICITY; NONHUMAN; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECT; ELECTROSTIMULATION; GENETICS; IMMEDIATE EARLY GENE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE; SYNAPTIC TRANSMISSION; TEMPORAL LOBE EPILEPSY; TIME; WISTAR RAT;

AMYGDALA; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; EPILEPSY, TEMPORAL LOBE; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; HIPPOCAMPUS; MALE; NEURONAL PLASTICITY; PIRACETAM; RATS; RATS, WISTAR; RNA, MESSENGER; SEIZURES; SYNAPSES; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 77951252768     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-9     Document Type: Article

References (82)

1. Heaney DC, MacDonald BK, Everitt A, Stevenson S, Leonardi GS, Wilkinson P, et al. Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 2002, 325:1013-1016. 10.1136/bmj.325.7371.1013, 131020, 12411362.
2. Guerrini R, Casari G, Marini C. The genetic and molecular basis of epilepsy. Trends in Molecular Medicine 2003, 9:300-306. 10.1016/S1471-4914(03)00116-3, 12900217.
3. Scheffer IE, Berkovic SF. The genetics of human epilepsy. Trends in Pharmacological Sciences 2003, 24:428-433. 10.1016/S0165-6147(03)00194-9, 12915053.
4. Herman ST. Epilepsy after brain insult: targeting epileptogenesis. Neurology 2002, 59:S21-S26.
5. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 2002, 50:105-123. 10.1016/S0920-1211(02)00073-6, 12151122.
6. Aronica E, Gorter JA. Gene Expression Profile in Temporal Lobe Epilepsy. Neuroscientist 2007, 13:100-108. 10.1177/1073858406295832, 17404370.
7. Mathern GW, Babb TL, Leite JP, Pretorius K, Yeoman KM, Kuhlman PA. The pathogenic and progressive features of chronic human hippocampal epilepsy. Epilepsy Res 1996, 26:151-161. 10.1016/S0920-1211(96)00052-6, 8985697.
8. Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 1969, 25:295-330. 10.1016/0014-4886(69)90128-9, 4981856.
9. Michalakis M, Holsinger D, Ikeda-Douglas C, Cammisuli S, Ferbinteanu J, DeSouza C, et al. Development of spontaneous seizures over extended electrical kindling. I. Electrographic, behavioral, and transfer kindling correlates. Brain Res 1998, 793:197-211. 10.1016/S0006-8993(98)00155-3, 9630628.
10. Sutula T, He XX, Cavazos J, Scott G. Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science 1988, 239:1147-1150. 10.1126/science.2449733, 2449733.
11. Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 1998, 284:474-479.
12. Stratton SC, Large CH, Cox B, Davies G, Hagan RM. Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model. Epilepsy Res 2003, 53:95-106. 10.1016/S0920-1211(02)00254-1, 12576171.
13. Yan HD, Ji-qun C, Ishihara K, Nagayama T, Serikawa T, Sasa M. Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER). Epilepsia 2005, 46:1170-1177. 10.1111/j.1528-1167.2005.35204.x, 16060925.
14. Glien M, Brandt C, Potschka H, Loscher W. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia 2002, 43:350-357. 10.1046/j.1528-1157.2002.18101.x, 11952764.
15. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000, 55:236-242.
16. Krauss GL, Betts T, Abou-Khalil B, Gergey G, Yarrow H, Miller A. Levetiracetam treatment of idiopathic generalised epilepsy. Seizure 2003, 12:617-620. 10.1016/S1059-1311(03)00139-0, 14630506.
17. Stodieck S, Steinhoff BJ, Kolmsee S, van Rijckevorsel K. Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges. Seizure 2001, 10:583-587. 10.1053/seiz.2001.0582, 11792161.
18. Klitgaard H, Matagne A, Gobert J, Wulfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 1998, 353:191-206. 10.1016/S0014-2999(98)00410-5, 9726649.
19. Loscher W, Honack D. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol 1993, 232:147-158. 10.1016/0014-2999(93)90768-D, 8467854.
20. Noyer M, Gillard M, Matagne A, Henichart JP, Wulfert E. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol 1995, 286:137-146. 10.1016/0014-2999(95)00436-O, 8605950.
21. Fuks B, Gillard M, Michel P, Lynch B, Vertongen P, Leprince P, et al. Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines. Eur J Pharmacol 2003, 478:11-19. 10.1016/j.ejphar.2003.08.033, 14555179.
22. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004, 101:9861-9866. 10.1073/pnas.0308208101, 470764, 15210974.
23. Buckley K, Kelly RB. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J Cell Biol 1985, 100:1284-1294. 10.1083/jcb.100.4.1284, 2113776, 2579958.
24. Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci USA 1999, 96:15268-15273. 10.1073/pnas.96.26.15268, 24809, 10611374.
25. Janz R, Goda Y, Geppert M, Missler M, Sudhof TC. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 1999, 24:1003-1016. 10.1016/S0896-6273(00)81046-6, 10624962.
26. Becker AJ, Chen J, Zien A, Sochivko D, Normann S, Schramm J, et al. Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy. European Journal of Neuroscience 2003, 18:2792-2802. 10.1111/j.1460-9568.2003.02993.x, 14656328.
27. Lukasiuk K, Kontula L, Pitkanen A. cDNA profiling of epileptogenesis in the rat brain. Eur J Neurosci 2003, 17:271-279. 10.1046/j.1460-9568.2003.02461.x, 12542663.
28. Hendriksen H, Datson NA, Ghijsen WE, van Vliet EA, da Silva FH, Gorter JA, et al. Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post-status epilepticus model. Eur J Neurosci 2001, 14:1475-1484. 10.1046/j.0953-816x.2001.01778.x, 11722609.
29. Racine RJ. Modification of seizure activity by electrical stimulation. I. After-discharge threshold. Electroencephalogr Clin Neurophysiol JID - 0375035 1972, 32:269-279.
30. Jorgensen M, Bevort M, Kledal TS, Hansen BV, Dalgaard M, Leffers H. Differential display competitive polymerase chain reaction: an optimal tool for assaying gene expression. Electrophoresis 1999, 20:230-240.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
32. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 2000, 285:194-204. 10.1006/abio.2000.4753, 11017702.
33. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999, 270:41-49. 10.1006/abio.1999.4085, 10328763.
34. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45. 10.1093/nar/29.9.e45, 55695, 11328886.
35. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971. 10.1126/science.1354393, 1354393.
36. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 1993, 11:371-386. 10.1016/0896-6273(93)90192-T, 8352945.
37. Wallace CS, Lyford GL, Worley PF, Steward O. Differential Intracellular Sorting of Immediate Early Gene mRNAs Depends on Signals in the mRNA Sequence. J Neurosci 1998, 18:26-35.
38. Burazin TC, Gundlach AL. Rapid and transient increases in cellular immediate early gene and neuropeptide mRNAs in cortical and limbic areas after amygdaloid kindling seizures in the rat. Epilepsy Res 1996, 26:281-293. 10.1016/S0920-1211(96)00060-5, 8985707.
39. Lanahan A, Worley P. Immediate-early genes and synaptic function. Neurobiol Learn Mem 1998, 70:37-43. 10.1006/nlme.1998.3836, 9753585.
40. Husum H, Bolwig TG, Sanchez C, Mathe AA, Hansen SL. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties. Epilepsy Behav 2004, 5:204-215. 10.1016/j.yebeh.2003.12.004, 15123022.
41. Gu J, Lynch BA, Anderson D, Klitgaard H, Lu S, Elashoff M, et al. The antiepileptic drug levetiracetam selectively modifies kindling-induced alterations in gene expression in the temporal lobe of rats. Eur J Neurosci 2004, 19:334-345. 10.1111/j.0953-816X.2003.03106.x, 14725628.
42. Chen F, Madsen TM, Wegener G, Nyengaard JR. Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus. Eur Neuropsychopharmacol 2009, 19:329-338. 10.1016/j.euroneuro.2008.12.007, 19176277.
43. Zha XM, Green SH, Dailey ME. Regulation of hippocampal synapse remodeling by epileptiform activity. Mol Cell Neurosci 2005, 29:494-506. 10.1016/j.mcn.2005.04.007, 15953736.
44. Tu B, Bazan NG. Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp Neurol 2003, 179:167-175. 10.1016/S0014-4886(02)00019-5, 12618123.
45. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993, 11:371-386. 10.1016/0896-6273(93)90192-T, 8352945.
46. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res 1995, 23:4907-4912. 10.1093/nar/23.23.4907, 307482, 8532536.
47. Bender H, Wang Z, Schuster N, Krieglstein K. TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu. J Neurosci Res 2004, 75:344-352. 10.1002/jnr.10856, 14743447.
48. Eisch AJ, Lammers CH, Yajima S, Mouradian MM, Nestler EJ. In vivo regulation of glial cell line-derived neurotrophic factor-inducible transcription factor by kainic acid. Neuroscience 1999, 94:629-636. 10.1016/S0306-4522(99)00302-4, 10579223.
49. Yajima S, Lammers CH, Lee SH, Hara Y, Mizuno K, Mouradian MM. Cloning and characterization of murine glial cell-derived neurotrophic factor inducible transcription factor (MGIF). J Neurosci 1997, 17:8657-8666.
50. Hefferan TE, Subramaniam M, Khosla S, Riggs BL, Spelsberg TC. Cytokine-specific induction of the TGF-beta inducible early gene (TIEG): regulation by specific members of the TGF-beta family. J Cell Biochem 2000, 78:380-390. 10.1002/1097-4644(20000901)78:3<380::AID-JCB4>3.0.CO;2-L, 10861837.
51. Makarenkova H, Sugiura H, Yamagata K, Owens G. Alternatively spliced variants of protocadherin 8 exhibit distinct patterns of expression during mouse development. Biochim Biophys Acta 2005, 1681:150-156.
52. Yamagata K, Andreasson KI, Sugiura H, Maru E, Dominique M, Irie Y, et al. Arcadlin is a neural activity-regulated cadherin involved in long term potentiation. J Biol Chem 1999, 274:19473-1979. 10.1074/jbc.274.27.19473, 10383464.
53. Yasuda S, Tanaka H, Sugiura H, Okamura K, Sakaguchi T, Tran U, et al. Activity-induced protocadherin arcadlin regulates dendritic spine number by triggering N-cadherin endocytosis via TAO2beta and p38 MAP kinases. Neuron 2007, 56:456-471. 10.1016/j.neuron.2007.08.020, 2424284, 17988630.
54. Tsui CC, Copeland NG, Gilbert DJ, Jenkins NA, Barnes C, Worley PF. Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. J Neurosci 1996, 16:2463-2478.
55. Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL, et al. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 1997, 386:284-288. 10.1038/386284a0, 9069287.
56. Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG, et al. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 1995, 14:433-445. 10.1016/0896-6273(95)90299-6, 7857651.
57. Bottai D, Guzowski JF, Schwarz MK, Kang SH, Xiao B, Lanahan A, et al. Synaptic activity-induced conversion of intronic to exonic sequence in Homer 1 immediate early gene expression. J Neurosci 2002, 22:167-175.
58. Yamazaki M, Matsuo R, Fukazawa Y, Ozawa F, Inokuchi K. Regulated expression of an actin-associated protein, synaptopodin, during long-term potentiation. J Neurochem 2001, 79:192-199. 10.1046/j.1471-4159.2001.00552.x, 11595771.
59. Roth SU, Sommer C, Mundel P, Kiessling M. Expression of synaptopodin, an actin-associated protein, in the rat hippocampus after limbic epilepsy. Brain Pathol 2001, 11:169-181.
60. Inokuchi K, Kato A, Hiraia K, Hishinuma F, Inoue M, Ozawa F. Increase in activin beta A mRNA in rat hippocampus during long-term potentiation. FEBS Lett 1996, 382:48-52. 10.1016/0014-5793(96)00135-4, 8612762.
61. Andreasson K, Worley PF. Induction of beta-A activin expression by synaptic activity and during neocortical development. Neuroscience 1995, 69:781-796. 10.1016/0306-4522(95)00245-E, 8596648.
62. Isackson PJ, Huntsman MM, Murray KD, Gall CM. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 1991, 6:937-948. 10.1016/0896-6273(91)90234-Q, 2054188.
63. Elmer E, Kokaia Z, Kokaia M, Carnahan J, Nawa H, Lindvall O. Dynamic changes of brain-derived neurotrophic factor protein levels in the rat forebrain after single and recurring kindling-induced seizures. Neuroscience 1998, 83:351-362. 10.1016/S0306-4522(97)00387-4, 9460745.
64. Ying SW, Futter M, Rosenblum K, Webber MJ, Hunt SP, Bliss TV, et al. Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 2002, 22:1532-1540.
65. Messaoudi E, Ying SW, Kanhema T, Croll SD, Bramham CR. Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo. J Neurosci 2002, 22:7453-7461.
66. Kovalchuk Y, Hanse E, Kafitz KW, Konnerth A. Postsynaptic Induction of BDNF-Mediated Long-Term Potentiation. Science 2002, 295:1729-1734. 10.1126/science.1067766, 11872844.
67. Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 1996, 16:1137-1145. 10.1016/S0896-6273(00)80140-3, 8663990.
68. Shin C, McNamara JO, Morgan JI, Curran T, Cohen DR. Induction of c-fos mRNA expression by afterdischarge in the hippocampus of naive and kindled rats. J Neurochem 1990, 55:1050-1055. 10.1111/j.1471-4159.1990.tb04595.x, 2117045.
69. Morgan JI, Cohen DR, Hempstead JL, Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 1987, 237:192-197. 10.1126/science.3037702, 3037702.
70. Cole AJ, Saffen DW, Baraban JM, Worley PF. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 1989, 340:474-476. 10.1038/340474a0, 2547165.
71. Watanabe Y, Johnson RS, Butler LS, Binder DK, Spiegelman BM, Papaioannou VE, et al. Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy. J Neurosci 1996, 16:3827-3836.
72. Deller T, Korte M, Chabanis S, Drakew A, Schwegler H, Stefani GG, et al. Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity. Proc Natl Acad Sci USA 2003, 100:10494-10499. 10.1073/pnas.1832384100, 193589, 12928494.
73. Konietzko U, Kauselmann G, Scafidi J, Staubli U, Mikkers H, Berns A, et al. Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP. EMBO J 1999, 18:3359-3369. 10.1093/emboj/18.12.3359, 1171416, 10369676.
74. Liang D, Seyfried TN. Genes differentially expressed in the kindled mouse brain. Brain Res Mol Brain Res 2001, 96:94-102. 10.1016/S0169-328X(01)00287-X, 11731014.
75. Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, et al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 2004, 24:2667-2677. 10.1523/JNEUROSCI.5377-03.2004, 15028759.
76. Hosford DA, Simonato M, Cao Z, Garcia-Cairasco N, Silver JM, Butler L, et al. Differences in the anatomic distribution of immediate-early gene expression in amygdala and angular bundle kindling development. J Neurosci 1995, 15:2513-2523.
77. Labiner DM, Butler LS, Cao Z, Hosford DA, Shin C, McNamara JO. Induction of c-fos mRNA by kindled seizures: complex relationship with neuronal burst firing. J Neurosci 1993, 13:744-751.
78. Arion D, Sabatini M, Unger T, Pastor J, onso-Nanclares L, Ballesteros-Yanez I, et al. Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy. Neurobiology of Disease 2006, 22:374-387. 10.1016/j.nbd.2005.12.012, 16480884.
79. Margineanu DG, Wulfert E. Inhibition by levetiracetam of a non-GABAA receptor-associated epileptiform effect of bicuculline in rat hippocampus. Br J Pharmacol 1997, 122:1146-1150. 10.1038/sj.bjp.0701476, 1565035, 9401779.
80. Margineanu DG, Wulfert E. ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo. Eur J Pharmacol 1995, 286:321-325. 10.1016/0014-2999(95)00597-8, 8608796.
81. Niespodziany I, Klitgaard H, Margineanu DG. Desynchronizing effect of levetiracetam on epileptiform responses in rat hippocampal slices. Neuroreport 2003, 14:1273-1276. 10.1097/00001756-200307010-00017, 12824774.
82. Georg MD, Klitgaard H. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res 2000, 42:281-285. 10.1006/phrs.2000.0689, 10987984.